Small Cell Lung Carcinoma D055752

Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases » Lung Neoplasms » Carcinoma, Bronchogenic » Small Cell Lung Carcinoma

Description

A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA).   MeSH

Hierarchy View


Approved Indicated Drugs (2)

Phase 2 Indicated Drugs (197)


Organization Involved with Phase 3 Indications (90)

Organization Involved with Phase 2 Indications (254)

Addario Lung Cancer Medical Institute

Advanced Accelerator Applications

Advaxis, Inc.

Advenchen Laboratories, LLC

Aeglea Biotherapeutics

Aileron Therapeutics

Ajou University

Alliance Foundation Trials

Altor Bioscience

AnewPharma

Ariad Pharmaceuticals

Ascentage Pharma Group Inc.

Ascenta Therapeutics

Astellas

Astex Pharmaceuticals, Inc.

Aultman Hospital

AurKa Pharma Inc.

AUSL della Romagna-RAVENNA

Austin Health

Azienda Ospedaliera San Camillo Forlanini

Badalona Hospital Germans Trias i Pujol

Barts & The London NHS Trust

Bayer

Big Ten Cancer Research Consortium

Biontech

BioXcel Therapeutics Inc

Boehringer Ingelheim

Boston University

Bureau of Science and Technology of Guangxi Province, China

Burzynski Research Institute

California Cancer Center

Cancer Insight, LLC

Cancer Research and Biostatistics Clinical Trials Consortium

Cancer Research UK

Cancer Treatment Centers of America

Cantonal Hospital of St. Gallen

Cantonal Hospital Winterthur

Catholic University of Korea

Centre Georges Francois Leclerc

Chang Gung University

China Medical University

Chinese Academy of Medical Sciences

Chonbuk National University

Chung-Ang University

City of Hope National Medical Center

Clinica Universidad de Navarra

Clirest s.r.l.

Clovis Oncology

CytRx

Dartmouth University

Duke University

ECOG-ACRIN Cancer Research Group

Emory University

European Thoracic Oncology Platform

First Hospital of Shijiazhuang City

First People's Hospital of Foshan

Frontier Science Foundation, Hellas

Fudan University

G1 Therapeutics, Inc.

Gachon University

Gemin X

Genentech

Genzyme

Georgetown University

Ghent University

Groupe Hospitalier Paris Saint Joseph

Gruppo Oncologico Italiano di Ricerca Clinica

Guangxi Medical University

Guangzhou Medical University

Guangzhou Panyu Central Hospital

Guizhou Medical University

Gundersen Health System

Gynecologic Oncology Group

Harpoon Therapeutics

Harvard University

Hellenic Cooperative Oncology Group

Hellenic Oncology Research Group

Helse Møre og Romsdal HF

Henan Medical University

Hikma

Hoosier Cancer Research Network

Hospital de Sagunto

Hospital General Universitario Gregorio Marañon

Hospital General Universitario Morales Meseguer

Hospital Universitario Carlos Haya

Huazhong University of Science and Technology

Humanitas University

Icahn School of Medicine at Mount Sinai

IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest

ImmunogenX

Immunomedics

Indiana University

Innovent Biologics (Suzhou) Co. Ltd.

Institut de Cancerologie de l'Ouest Paul Papin

Institute of Oncology Dr. Rosell (IOR)

IQVIA

Istituto Clinico Humanitas - Rozzano (MI), Italy

Istituto Nazionale per lo Studio e la Cura dei Tumori

Istituto Oncologico Veneto IRCCS

Istituto Toscano Tumori

James Graham Brown Cancer Center

Japan Multinational Trial Organization

Jeroen Bosch Ziekenhuis

Jilin University

Johannes Gutenburg University

Johns Hopkins University

J. W. Goethe University

Karyopharm Therapeutics Inc

Keimyung University

K-Group Beta

Kindai University

Kyoto University

Kyowa Hakko Kirin

Kyung Hee University

Lee's Pharmaceutical

Levanger Hospital

Ludwig Institute for Cancer Research

Lungenklinik Hemer

Luye Pharma

Maastricht University

Marche Polytechnic University

McMaster University

Medical University of South Carolina

MedSIR

Memorial Sloan-Kettering Cancer Center

Merck Serono

Mereo BioPharma

Metropolitan hospital of Piraeus, Greece

Threshold Pharmaceuticals

Tianjin Medical University

Translational Research in Oncology

TriStar Nashville

Tsinghua University

Tufts University

United States Army

Universidad de Cordoba

University Alicante

University Hospital of North Norway

University Hospital Quirón Dexeus, Barcelona

University of Alabama, Birmingham

University of Alberta

University of Barcelona

University of Bergen

University of Bern

University of Bologna

University of Calgary

University of California, Los Angeles

University of California, San Francisco

University of Cambridge

University of Cincinnati

University of Cologne

University of Crete

University of Electronic Science and Technology of China

University of Geneva

University of Heidelberg

University of Iowa

University of Kentucky

University of Louisville

University of Lyon

University of Maryland

University of Michigan

University of Montreal

University of North Carolina at Chapel Hill

University of Pittsburgh

University of Rochester

University of South Florida

University of Stavanger

University of Texas at Houston

University of Toyama

University of Turin

University of Ulsan

University of Valencia

University of Washington

University of Western Brittany

US Biotest

Vertex

Vestre Viken Ringerike Sykehus

Vion Pharmaceuticals

Vita-Salute University of Milano. Italy

Wakayama Medical University

Wake Forest University

Washington University in St. Louis

Wayne State University

Wenzhou Medical University

Xcovery

Yale University

Yonsei University

Zenith Epigenetics

Zhejiang University

Zhengzhou University

Organization Involved with Other Experimental Indications (6)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.